(Q39776827)

14 September 2017

Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population (English)

1 reference

14 September 2017

1 reference

8

Frank B Hu

1 reference

14 September 2017

Yan Feng

1

1 reference

14 September 2017

Xiumei Hong

2

1 reference

14 September 2017

Zhiping Li

3

1 reference

14 September 2017

Wenbin Zhang

4

1 reference

14 September 2017

Delai Jin

5

1 reference

14 September 2017

Xue Liu

6

1 reference

14 September 2017

Yan Zhang

7

1 reference

14 September 2017

Lee-Jen Wei

9

1 reference

14 September 2017

Tonghua Zang

10

1 reference

14 September 2017

Xiping Xu

11

1 reference

14 September 2017

Xin Xu

12

1 reference

14 September 2017

language of work or name

1 reference

1 November 2006

1 reference

14 September 2017

1 reference

14 September 2017

14

1 reference

14 September 2017

2089-2098

1 reference

14 September 2017

11

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

14 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Cardiovascular morbidity and mortality associated with the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

31 March 2020

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

The metabolic syndrome: prevalence in worldwide populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence of the metabolic syndrome and overweight among adults in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence and factor analysis of metabolic syndrome in an urban Korean population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

High prevalence of metabolic syndrome in Hong Kong Chinese--comparison of three diagnostic criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

The prevalence of the metabolic syndrome in Korean adults: comparison of WHO and NCEP criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence of the metabolic syndrome among South Korean adults: the Ansan study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

The metabolic syndrome--a new worldwide definition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Genetic and environmental influences on total-body and central abdominal fat: the effect of physical activity in female twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence of the metabolic syndrome among Omani adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Regional obesity and risk of cardiovascular disease; the Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Abdominal obesity is associated with insulin resistance and reduced glycogen synthetase activity in skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Excess abdominal adiposity remains correlated with altered lipid concentrations in healthy older women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.244

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.244

1 reference

14 September 2017

1 reference